Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Simbolo, A. Mafficini, K. Sikora, M. Fassan, S. Barbi, V. Corbo, L. Mastracci, B. Rusev, F. Grillo, C. Vicentini, R. Ferrara, S. Pilotto, F. Davini, G. Pelosi, R. Lawlor, M. Chilosi, G. Tortora, E. Bria, G. Fontanini, M. Volante, A. Scarpa (2016)
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin‐remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2DThe Journal of Pathology, 241
G. Pelosi, A. Fabbri, M. Cossa, A. Sonzogni, B. Valeri, L. Righi, M. Papotti (2015)
What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?Seminars in diagnostic pathology, 32 6
M. Mezzetti, F. Raveglia, T. Panigalli, L. Giuliani, F. Giudice, S. Meda, S. Conforti (2003)
Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification.The Annals of thoracic surgery, 76 6
G. Pelosi, G. Rindi, W. Travis, M. Papotti (2014)
Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical PracticeJournal of Thoracic Oncology, 9
H. Asamura, T. Kameya, Y. Matsuno, M. Noguchi, H. Tada, Y. Ishikawa, T. Yokose, Shi‐Xu Jiang, Takeshi Inoue, K. Nakagawa, K. Tajima, K. Nagai (2006)
Neuroendocrine neoplasms of the lung: a prognostic spectrum.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 1
A. Fabbri, M. Cossa, A. Sonzogni, M. Papotti, L. Righi, G. Gatti, P. Maisonneuve, B. Valeri, U. Pastorino, G. Pelosi (2017)
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are appliedVirchows Archiv, 470
G. Pelosi, Jaime Rodriguez, G. Viale, J. Rosai (2005)
Typical and Atypical Pulmonary Carcinoid Tumor Overdiagnosed as Small-Cell Carcinoma on Biopsy Specimens: A Major Pitfall in the Management of Lung Cancer PatientsThe American Journal of Surgical Pathology, 29
Dorian Swarts, M. Rudelius, S. Claessen, J. Cleutjens, S. Seidl, M. Volante, F. Ramaekers, E. Speel (2017)
Limited additive value of the Ki‐67 proliferative index on patient survival in World Health Organization‐classified pulmonary carcinoidsHistopathology, 70
N. Raj, E. Valentino, M. Capanu, Laura Tang, O. Basturk, B. Untch, P. Allen, D. Klimstra, D. Reidy‐Lagunes (2017)
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly DifferentiatedPancreas, 46
F. Bosman (2010)
WHO Classification of Tumours of the Digestive System
A. Quinn, A. Chaturvedi, D. Nonaka (2017)
High-grade Neuroendocrine Carcinoma of the Lung With Carcinoid Morphology: A Study of 12 CasesThe American Journal of Surgical Pathology, 41
N. Rekhtman, M. Pietanza, M. Hellmann, J. Naidoo, Arshi Arora, H. Won, D. Halpenny, Hangjun Wang, S. Tian, A. Litvak, P. Paik, A. Drilon, N. Socci, J. Poirier, R. Shen, M. Berger, A. Moreira, W. Travis, C. Rudin, M. Ladanyi (2016)
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like SubsetsClinical Cancer Research, 22
A. Walts, Delma Ines, A. Marchevsky (2012)
Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumorsModern Pathology, 25
C. McCall, C. Shi, Toby Cornish, D. Klimstra, Laura Tang, O. Basturk, Liew Mun, Trevor Ellison, elliot fishman, M. Choti, R. Schulick, B. Edil, R. Hruban (2013)
Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic RateThe American Journal of Surgical Pathology, 37
M. Beasley, F. Thunnissen, E. Brambilla, P. Hasleton, R. Steele, S. Hammar, T. Colby, M. Sheppard, Y. Shimosato, M. Koss, R. Falk, W. Travis (2000)
Pulmonary atypical carcinoid: predictors of survival in 106 cases.Human pathology, 31 10
W. Travis (2015)
WHO classification of tumours of the lung, pleura, thymus and heart
Laura Tang, O. Basturk, J. Sue, D. Klimstra (2016)
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the PancreasThe American Journal of Surgical Pathology, 40
M. Milione, P. Maisonneuve, F. Spada, A. Pellegrinelli, P. Spaggiari, L. Albarello, E. Pisa, M. Barberis, A. Vanoli, R. Buzzoni, S. Pusceddu, L. Concas, F. Sessa, E. Solcia, C. Capella, N. Fazio, S. Rosa (2016)
The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic CategoriesNeuroendocrinology, 104
V. Costes, C. Marty-ané, M. Picot, Isabelle Serre, J. Pujol, H. Mary, P. Baldet (1995)
Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study.Human pathology, 26 7
W. Travis (2010)
Advances in neuroendocrine lung tumors.Annals of oncology : official journal of the European Society for Medical Oncology, 21 Suppl 7
A. Fabbri, M. Cossa, A. Sonzogni, P. Bidoli, S. Canova, D. Cortinovis, M. Abbate, F. Calabrese, N. Nannini, F. Lunardi, G. Rossi, S. Rosa, C. Capella, E. Tamborini, F. Perrone, A. Busico, I. Capone, B. Valeri, U. Pastorino, A. Albini, G. Pelosi (2017)
Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shiftVirchows Archiv, 471
Laura Tang, B. Untch, D. Reidy, E. O’Reilly, D. Dhall, L. Jih, O. Basturk, P. Allen, D. Klimstra (2015)
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine CarcinomasClinical Cancer Research, 22
Milione Massimo, Maisonneuve Patrick, Spada Francesca, P. Alessio, S. Paola, A. Luca, Pisa Eleonora, Barberis Massimo, Vanoli Alessandro, Buzzoni Roberto, Pusceddu Sara, Concas Laura, Sessa Fausto, S. Enrico, C. Carlo, F. Nicola, Landi Stefano (2016)
Supplementary Material for: The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories
M. Rugge, M. Fassan, Roberto Clemente, G. Rizzardi, L. Giacomelli, G. Pennelli, C. Mescoli, D. Segat, F. Rea (2008)
Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian PatientsClinical Cancer Research, 14
Luc Morris, N. Riaz, A. Desrichard, Y. Şenbabaoğlu, A. Hakimi, V. Makarov, J. Reis-Filho, Timothy Chan (2016)
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survivalOncotarget, 7
G. Rindi, Catherine Klersy, F. Inzani, Giovanni Fellegara, L. Ampollini, A. Ardizzoni, N. Campanini, P. Carbognani, T. Pas, Domenico Galetta, P. Granone, L. Righi, M. Rusca, Lorenzo Spaggiari, Marcello Tiseo, Giuseppe Viale, M. Volante, M. Papotti, G. Pelosi (2013)
Grading the neuroendocrine tumors of the lung: an evidence-based proposal.Endocrine-related cancer, 21 1
P. Filosso, O. Rena, F. Guerrera, P. Casado, D. Sagan, F. Raveglia, A. Brunelli, S. Welter, L. Gust, C. Pompili, C. Casadio, G. Bora, A. Álvarez, W. Załuska, A. Baisi, C. Roesel, P. Thomas (2015)
Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 48 1
G. Maurizi, Mohsen Ibrahim, C. Andreetti, A. D’Andrilli, A. Ciccone, L. Pomes, C. Menna, M. Pellegrini, F. Venuta, E. Rendina (2014)
Long-term results after resection of bronchial carcinoid tumour: evaluation of survival and prognostic factors.Interactive cardiovascular and thoracic surgery, 19 2
G. Pelosi, F. Pasini, F. Fraggetta, U. Pastorino, A. Iannucci, P. Maisonneuve, G. Arrigoni, G. Manzoni, E. Bresaola, G. Viale (2003)
Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.Lung cancer, 42 2
P. Filosso, E. Ruffini, S. Gangi, F. Guerrera, G. Bora, G. Ciccone, C. Galassi, P. Solidoro, P. Lybéris, A. Oliaro, A. Sandri (2014)
Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 45 3
M. Caplin, E. Baudin, P. Ferolla, Filosso Pl, M. Garcı́a-Yuste, E. Lim, K. Öberg, G. Pelosi, A. Perren, R. Rossi, R. Rossi, W. Travis (2015)
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.Annals of oncology : official journal of the European Society for Medical Oncology, 26 8
A. Warth, L. Fink, A. Fisseler‐Eckhoff, D. Jonigk, Marius Keller, G. Ott, R. Rieker, P. Sinn, S. Söder, A. Soltermann, K. Willenbrock, W. Weichert, O. Pathology (2013)
Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoidsVirchows Archiv, 462
Typical (TCs) and atypical carcinoids (ACs) are defined based on morphological criteria, and no grading system is currently accepted to further stratify these entities. The 2015 WHO classification restricts the Ki-67 role to biopsy or cytology samples, rather than for prognostic prediction. We aimed to investigate whether values and patterns of Ki-67 alone would allow for a clinically meaningful stratification of lung carcinoids, regardless of histological typing. Ki-67 proliferation index and pattern (homogeneous versus heterogeneous expression) were assessed in a cohort of 171 TCs and 68 ACs. Cases were subdivided into three Ki-67 ranges (<4/4–9/≥10%). Correlations with clinicopathological data, univariate and multivariate survival analyses were performed. The majority of cases (61.5%) belonged to the <4% Ki-67 range; 25.1 and 13.4% had a proliferation index of 4–9% and ≥10%, respectively. The <4% Ki-67 subgroup was significantly enriched for TCs (83%, p < 0.0001); ACs were more frequent in the subgroup showing Ki-67 ≥ 10% (75%, p < 0.0001). A heterogeneous Ki-67 pattern was preferentially seen in carcinoids with a Ki-67 ≥10% (38%, p < 0.02). Mean Ki-67 values ≥4 and ≥10% identified categories of poor prognosis both in terms of disease-free and overall survival (p = 0.003 and <0.0001). At multivariate analysis, the two thresholds did not retain statistical significance; however, a Ki-67 ≥ 10% identified a subgroup of dismal prognosis even within ACs (p = 0.03) at univariate analysis. Here, we describe a subgroup of lung carcinoids showing brisk proliferation activity within the necrosis and/or mitotic count-based categories. These patients were associated with specific clinicopathological characteristics, to some extent regardless of histological subtyping.
Virchows Archiv – Springer Journals
Published: Jun 19, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.